Curriculum for Subspecialty Training in Maternal and Fetal Medicine

Total Page:16

File Type:pdf, Size:1020Kb

Curriculum for Subspecialty Training in Maternal and Fetal Medicine Maternal and Fetal Medicine Curriculum Curriculum for Subspecialty Training in Maternal and Fetal Medicine Module 1 Medical Complications of Pregnancy Module 2 Genetics Module 3 Structural Fetal Abnormalities Module 4 Antenatal Complications Module 5 Intrapartum Complications Module 6 Infectious Diseases 1 Last updated February 2013 Maternal and Fetal Medicine Curriculum Module 1 Medical complications of pregnancy 1.1 Hypertension Objectives Manage a case of chronic hypertension, including: Counsel regarding fetal and maternal risks 1. To be able to carry out appropriate assessment (including long-term health implications. and management of women with chronic hypertension. Arrange appropriate investigations. 2. To be able to carry out appropriate assessment institute and modify drug therapy. and management of women with pregnancy- Plan delivery and postnatal care. induced hypertension, pre-eclampsia and Refer, where appropriate, for further assessment associated complications. and treatment. Chronic hypertension Professional skills and attitudes Knowledge criteria Ability to take an appropriate history and conduct an examination to screen for secondary causes and Definition and diagnosis: complications of chronic hypertension. Measurement of blood pressure in pregnancy, including validated devices. Ability to perform and interpret appropriate Impact of pregnancy on blood pressure. investigations. Superimposed pre-eclampsia. Prevalence (primary and secondary causes). Ability to formulate, implement and, where appropriate, modify a multidisciplinary management Pathophysiology: plan. Acute hypertension. Chronic hypertension (including end-organ Ability to manage antihypertensive drug therapy in damage). antenatal and postnatal periods. Management: Ability to liaise with primary care and physicians in Screening for common causes of secondary management of hypertension. hypertension. Ability to counsel women about: Pregnancy management, including fetal monitoring. maternal and fetal risks Maternal and fetal risks. safety of antihypertensive therapy Contraception. contraception Pharmacology, including adverse effects: Training support Anti-adrenergics (e.g. propranolol, labetalol, Observation of and discussion with senior oxprenolol). medical staff. Calcium channel blockers (e.g. nifedipine). Appropriate postgraduate courses Vasodilators (e.g. hydralazine). (e.g. ICL/RCP/BMFMS Maternal Complications ACE inhibitors (e.g. lisinopril). in Pregnancy). Attendance at maternal medicine and Outcome: long-term and cardiovascular risks. hypertension clinics. Attachments in: Clinical competency o obstetric anaesthesia Take an appropriate medical history from a woman o intensive care unit/high-dependency unit with pre-existing hypertension: Personal study. family history secondary causes of chronic hypertension Evidence complications of chronic hypertension Log of experience and competence. outcomes of previous pregnancies Mini-CEX. drug therapy. Case-based discussions. Perform an examination to screen for: secondary causes of hypertension complications of hypertension. 2 Last updated February 2013 MFM Curriculum Pre-eclampsia Knowledge criteria Professional skills and attitudes Definition and diagnosis: Ability to take an appropriate history and conduct an pregnancy-induced hypertension (PIH) examination to assess a woman with pre-eclampsia. proteinuria prevalence. Ability to perform and interpret appropriate investigations. Pathophysiology: placental pathology Ability to formulate list of differential diagnoses. endothelial dysfunction and systemic manifestations Ability to formulate, implement and, where oxidative stress. appropriate, modify a multidisciplinary management plan. Prediction (see 4.2). Ability to manage antihypertensive drug therapy in Management of severe pre-eclampsia: antenatal and postnatal periods. maternal and fetal risks maternal monitoring, including indications for Ability to liaise with primary care and physicians in invasive monitoring) management of hypertension. fetal monitoring management of complications Ability to counsel women about: HELLP syndrome maternal and fetal risks Eclampsia, including differential diagnosis safety of anti-hypertensive therapy convulsions, altered consciousness (see 1.18) recurrence risks and future management (see cerebrovascular accident (see 1.9) 4.2) pulmonary oedema, acute respiratory distress contraception. syndrome (see 1.5) contraception. Training support Observation of and discussion with senior Pharmacology, including adverse effects: medical staff. magnesium sulphate Appropriate postgraduate courses (e.g. frusemide. ICL/RCP/BMFMS Maternal Complications in Pregnancy). Outcome, including long-term cardiovascular risks. Attachments in: o obstetric anaesthesia Clinical competency o intensive care unit/high-dependency unit. Take an appropriate medical history from a woman Personal study. with pre-eclampsia: RCOG Green-top Guideline Management of family history Severe Pre-eclampsia/Eclampsia (No. 10A). symptoms of severe disease. Evidence Perform an examination to screen for complications in a woman with pre-eclampsia. Log of experience and competence. Mini-CEX. Manage a case of complex pre-eclampsia (or PIH) Case-based discussions. with: (a) HELLP, (b) severe hypertension, (c) eclampsia and (d) pulmonary oedema: counsel regarding fetal and maternal risks arrange and interpret appropriate investigations institute and modify drug therapy plan delivery and postnatal care refer, where appropriate, for further assessment and treatment. Manage a case of pre-eclampsia with acute renal failure: counsel regarding fetal and maternal risks arrange and interpret appropriate investigations refer to for further assessment and treatment. 3 Last updated February 2013 MFM Curriculum 1.2 Renal disease Objectives Manage a case of CRD: counsel regarding fetal and maternal risks 1. To be able to carry out, under supervision, appropriate assessment and management of arrange and interpret appropriate investigations women with pre-existing renal disease and renal institute and modify drug treatment transplants. plan delivery and postnatal care 2. To be able to carry out appropriate assessment refer where appropriate, for further assessment and management of women with pregnancy- and treatment. induced renal disease. Manage a case of renal transplant or ARF: Knowledge criteria counsel regarding fetal and maternal risks arrange and interpret appropriate investigations The kidney in normal pregnancy: refer for further assessment and treatment. anatomical changes, including hydronephrosis) functional changes Professional skills and attitudes interpretation renal function tests fluid and electrolyte balance. Ability to take an appropriate history and conduct an examination to assess a woman with CRD. Pre-existing renal disease (CRD): reflux nephropathy, glomerulonephritis, polycystic kidney Ability to perform and interpret appropriate disease (PKD): investigations. pathology Ability to formulate list of differential diagnoses. prevalence prepregnancy assessment Ability to formulate, implement and, where pregnancy management appropriate, modify a multidisciplinary management outcome (including genetic implications). plan. Renal transplant recipients: Ability to manage antihypertensive drug therapy in prepregnancy assessment antenatal and postnatal periods. diagnosis rejection pregnancy management Ability to liaise with nephrologists and intensivists in long term considerations the management of acute and CRD. pharmacology (including adverse effects) cyclosporine, tacrolimus Ability to counsel women about maternal and fetal azathioprine (see 1.10) risks, inheritance, recurrence risks, contraception. corticosteroids (see 1.5, 1.6, 1.10). Training support Acute renal failure (ARF) in pregnancy and the puerperium: Observation of and discussion with senior aetiology and diagnosis, including differential medical staff. diagnosis of abnormal renal function (see 1.18) Appropriate postgraduate courses (e.g. management and outcome ICL/RCP/BMFMS Maternal Complications in Pregnancy). indications for and principles of renal support. Attendance at renal medicine clinic. Urinary tract infection (see 6.15): differential Attachment in intensive care unit/high- diagnosis proteinuria (see 1.18). dependency unit. Personal study. Clinical competency Evidence Take an appropriate history from a woman with CRD: family history Log of experience and competence. complications Mini-CEX. outcome of previous pregnancies Case-based discussions. drug therapy. Perform an examination to screen for complications of CRD. 4 Last updated February 2013 MFM Curriculum 1.3 Cardiac disease Objectives Clinical competency 1. To be able to carry out, under supervision, Take an appropriate history from a woman with appropriate assessment and management of cardiac disease: women with pre-existing cardiac disease. family history previous operations/procedures 2. To be able to carry out, under supervision, complications of cardiac disease appropriate assessment and management of drug therapy. women with pregnancy-induced cardiac disease. Perform an examination to assess cardiac disease. Knowledge criteria The heart in normal pregnancy: Manage a case of congenital and acquired heart anatomical and functional changes, including disease in pregnancy: differential diagnosis heart murmur (see 1.18) counsel regarding fetal and maternal risks ECG, echocardiography and assessment of arrange and interpret appropriate investigations cardiac function. refer to
Recommended publications
  • Clinical Policy: Fetal Surgery in Utero for Prenatally Diagnosed
    Clinical Policy: Fetal Surgery in Utero for Prenatally Diagnosed Malformations Reference Number: CP.MP.129 Effective Date: 01/18 Coding Implications Last Review Date: 09/18 Revision Log Description This policy describes the medical necessity requirements for performing fetal surgery. This becomes an option when it is predicted that the fetus will not live long enough to survive delivery or after birth. Therefore, surgical intervention during pregnancy on the fetus is meant to correct problems that would be too advanced to correct after birth. Policy/Criteria I. It is the policy of Pennsylvania Health and Wellness® (PHW) that in-utero fetal surgery (IUFS) is medically necessary for any of the following: A. Sacrococcygeal teratoma (SCT) associated with fetal hydrops related to high output heart failure : SCT resecton: B. Lower urinary tract obstruction without multiple fetal abnormalities or chromosomal abnormalities: urinary decompression via vesico-amniotic shunting C. Ccongenital pulmonary airway malformation (CPAM) and extralobar bronchopulmonary sequestration with hydrops (hydrops fetalis): resection of malformed pulmonary tissue, or placement of a thoraco-amniotic shunt; D. Twin-twin transfusion syndrome (TTTS): treatment approach is dependent on Quintero stage, maternal signs and symptoms, gestational age and the availability of requisite technical expertise and include either: 1. Amnioreduction; or 2. Fetoscopic laser ablation, with or without amnioreduction when member is between 16 and 26 weeks gestation; E. Twin-reversed-arterial-perfusion (TRAP): ablation of anastomotic vessels of the acardiac twin (laser, radiofrequency ablation); F. Myelomeningocele repair when all of the following criteria are met: 1. Singleton pregnancy; 2. Upper boundary of myelomeningocele located between T1 and S1; 3.
    [Show full text]
  • Guide to Learning in Maternal-Fetal Medicine
    GUIDE TO LEARNING IN MATERNAL-FETAL MEDICINE First in Women’s Health The Division of Maternal-Fetal Medicine of The American Board of Obstetrics and Gynecology, Inc. 2915 Vine Street Dallas, TX 75204 Direct questions to: ABOG Fellowship Department 214.871.1619 (Main Line) 214.721.7526 (Fellowship Line) 214.871.1943 (Fax) [email protected] www.abog.org Revised 4/2018 1 TABLE OF CONTENTS I. INTRODUCTION ........................................................................................................................ 3 II. DEFINITION OF A MATERNAL-FETAL MEDICINE SUBSPECIALIST .................................... 3 III. OBJECTIVES ............................................................................................................................ 3 IV. GENERAL CONSIDERATIONS ................................................................................................ 3 V. ENDOCRINOLOGY OF PREGNANCY ..................................................................................... 4 VI. PHYSIOLOGY ........................................................................................................................... 6 VII. BIOCHEMISTRY ........................................................................................................................ 9 VIII. PHARMACOLOGY .................................................................................................................... 9 IX. PATHOLOGY .........................................................................................................................
    [Show full text]
  • Gtg-No-20B-Breech-Presentation.Pdf
    Guideline No. 20b December 2006 THE MANAGEMENT OF BREECH PRESENTATION This is the third edition of the guideline originally published in 1999 and revised in 2001 under the same title. 1. Purpose and scope The aim of this guideline is to provide up-to-date information on methods of delivery for women with breech presentation. The scope is confined to decision making regarding the route of delivery and choice of various techniques used during delivery. It does not include antenatal or postnatal care. External cephalic version is the topic of a separate RCOG Green-top Guideline No. 20a: ECV and Reducing the Incidence of Breech Presentation. 2. Background The incidence of breech presentation decreases from about 20% at 28 weeks of gestation to 3–4% at term, as most babies turn spontaneously to the cephalic presentation. This appears to be an active process whereby a normally formed and active baby adopts the position of ‘best fit’ in a normal intrauterine space. Persistent breech presentation may be associated with abnormalities of the baby, the amniotic fluid volume, the placental localisation or the uterus. It may be due to an otherwise insignificant factor such as cornual placental position or it may apparently be due to chance. There is higher perinatal mortality and morbidity with breech than cephalic presentation, due principally to prematurity, congenital malformations and birth asphyxia or trauma.1,2 Caesarean section for breech presentation has been suggested as a way of reducing the associated perinatal problems2,3 and in many countries in Northern Europe and North America caesarean section has become the normal mode of breech delivery.
    [Show full text]
  • Chapter 12 Vaginal Breech Delivery
    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 12 VAGINAL BREECH DELIVERY Learning Objectives By the end of this chapter, the participant will: 1. List the selection criteria for an anticipated vaginal breech delivery. 2. Recall the appropriate steps and techniques for vaginal breech delivery. 3. Summarize the indications for and describe the procedure of external cephalic version (ECV). Definition When the buttocks or feet of the fetus enter the maternal pelvis before the head, the presentation is termed a breech presentation. Incidence Breech presentation affects 3% to 4% of all pregnant women reaching term; the earlier the gestation the higher the percentage of breech fetuses. Types of Breech Presentations Figure 1 - Frank breech Figure 2 - Complete breech Figure 3 - Footling breech In the frank breech, the legs may be extended against the trunk and the feet lying against the face. When the feet are alongside the buttocks in front of the abdomen, this is referred to as a complete breech. In the footling breech, one or both feet or knees may be prolapsed into the maternal vagina. Significance Breech presentation is associated with an increased frequency of perinatal mortality and morbidity due to prematurity, congenital anomalies (which occur in 6% of all breech presentations), and birth trauma and/or asphyxia. Vaginal Breech Delivery Chapter 12 – Page 1 FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM External Cephalic Version External cephalic version (ECV) is a procedure in which a fetus is turned in utero by manipulation of the maternal abdomen from a non-cephalic to cephalic presentation. Diagnosis of non-vertex presentation Performing Leopold’s manoeuvres during each third trimester prenatal visit should enable the health care provider to make diagnosis in the majority of cases.
    [Show full text]
  • Symphysiotomy for Obstructed Labour
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Birmingham Research Portal Symphysiotomy for obstructed labour: a systematic review and meta-analysis Wilson, Amie; Truchanowicz, Ewa; Elmoghazy, Diaa; MacArthur, Christine; Coomarasamy, Aravinthan DOI: 10.1111/1471-0528.14040 License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Wilson, A, Truchanowicz, E, Elmoghazy, D, MacArthur, C & Coomarasamy, A 2016, 'Symphysiotomy for obstructed labour: a systematic review and meta-analysis', BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.14040 Link to publication on Research at Birmingham portal Publisher Rights Statement: Checked for eligibility: 06/05/2016 General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
    [Show full text]
  • The Identification and Validation of Neural Tube Defects in the General Practice Research Database
    THE IDENTIFICATION AND VALIDATION OF NEURAL TUBE DEFECTS IN THE GENERAL PRACTICE RESEARCH DATABASE Scott T. Devine A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the School of Public Health (Epidemiology). Chapel Hill 2007 Approved by Advisor: Suzanne West Reader: Elizabeth Andrews Reader: Patricia Tennis Reader: John Thorp Reader: Andrew Olshan © 2007 Scott T Devine ALL RIGHTS RESERVED - ii- ABSTRACT Scott T. Devine The Identification And Validation Of Neural Tube Defects In The General Practice Research Database (Under the direction of Dr. Suzanne West) Background: Our objectives were to develop an algorithm for the identification of pregnancies in the General Practice Research Database (GPRD) that could be used to study birth outcomes and pregnancy and to determine if the GPRD could be used to identify cases of neural tube defects (NTDs). Methods: We constructed a pregnancy identification algorithm to identify pregnancies in 15 to 45 year old women between January 1, 1987 and September 14, 2004. The algorithm was evaluated for accuracy through a series of alternate analyses and reviews of electronic records. We then created electronic case definitions of anencephaly, encephalocele, meningocele and spina bifida and used them to identify potential NTD cases. We validated cases by querying general practitioners (GPs) via questionnaire. Results: We analyzed 98,922,326 records from 980,474 individuals and identified 255,400 women who had a total of 374,878 pregnancies. There were 271,613 full-term live births, 2,106 pre- or post-term births, 1,191 multi-fetus deliveries, 55,614 spontaneous abortions or miscarriages, 43,264 elective terminations, 7 stillbirths in combination with a live birth, and 1,083 stillbirths or fetal deaths.
    [Show full text]
  • Presumptive Fertility and Fetoconsciousness: the Ideological Formation of ‘The Female Patient of Reproductive Age’
    PRESUMPTIVE FERTILITY AND FETOCONSCIOUSNESS: THE IDEOLOGICAL FORMATION OF ‘THE FEMALE PATIENT OF REPRODUCTIVE AGE’ A Thesis Submitted to the Temple University Graduate Board In Partial Fulfillment of the Requirements for the Degree MASTER OF ARTS by Emily S. Kirchner May 2017 Thesis Approvals: Nora L. Jones, PhD, Thesis Advisor, Center for Bioethics, Urban Health, and Policy i ABSTRACT Presumptive fertility is an ideology that leads us to treat not only pregnant women, but all female patients of reproductive age, with the presumption that they could be pregnant. This preoccupation with the possibility that a woman could be pregnant compels medical and social interventions that have adverse consequences on women’s lived experiences. It is important to pause now to examine this ideology. Despite our social realities -- there is a patient centered care movement in medical practice, American women are delaying and forgoing childbearing, abortion is safe and legal -- there is still a powerful medical and social process that subjugates womens’ bodies and lived experiences to their potential of being a mother. Fetoconsciousness, preoccupation with the fetus or hypothetical, not-yet-conceived, fetus privileges its potential embodiment over its mother’s reality. As a set of values that influence our beliefs, attitudes, and behaviors, the ideology of presumptive fertility is contextualized, critiqued, and challenged. ii TABLE OF CONTENTS ABSTRACT………………………………………………………………………………ii CHAPTER 1: INTRODUCTION…….….……………...……………………………...…1 CHAPTER 2: TRACING
    [Show full text]
  • (EXIT), a Resuscitation Option for Intra-Thoracic Foetal Pathologies
    Original article SWISS MED WKLY 2007;137:279–285 · www.smw.ch 279 Peer reviewed article Ex utero intrapartum treatment (EXIT), a resuscitation option for intra-thoracic foetal pathologies Christian Kerna, Michel Ange, Moralesb, Barbara Peiryc, Riccardo E. Pfisterc a Anaesthesia, University Hospital Geneva, Switzerland b Gynaecology and Obstetrics, University Hospital Geneva, Switzerland c Paediatrics, University Hospital Geneva, Switzerland Summary The ex utero intrapartum treatment (EXIT) requires a caesarean section that specifically differs procedure is designed to guarantee sufficient oxy- from the traditional caesarean section during genation for a foetus at risk of airway obstruction. which uterine tone is maintained to minimize ma- This is achieved by improving lung ventilation, ternal bleeding. To guarantee foetal oxygenation usually by establishing an airway during caesarean during the EXIT procedure, profound uterine delivery whilst preserving the foetal-placental cir- relaxation is desired. To gain time with optimal culation temporarily. Indications for the EXIT placental oxygenation in order to safely perform an procedure have extended from its original use in airway intervention in a baby at risk of hypoxia may reversing iatrogenic tracheal obstruction in con- require deep inhalation anaesthesia and/or to- genital diaphragmatic hernia to naturally occur- colytic agents. We review the EXIT procedure and ring upper airway obstructions. We report our present a case series from the University Hospital experience with a new and rarely mentioned indi- of Geneva that contrasts with the common indica- cation for the EXIT procedure, intra-thoracic tion for the EXIT procedure usually based on volume expansions. The elaboration of lowest risk upper airway obstruction by its exclusive indica- scenarios through balancing risks with alternative tion for intra-thoracic malformations/diseases.
    [Show full text]
  • Pretest Obstetrics and Gynecology
    Obstetrics and Gynecology PreTestTM Self-Assessment and Review Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the prod- uct information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. Obstetrics and Gynecology PreTestTM Self-Assessment and Review Twelfth Edition Karen M. Schneider, MD Associate Professor Department of Obstetrics, Gynecology, and Reproductive Sciences University of Texas Houston Medical School Houston, Texas Stephen K. Patrick, MD Residency Program Director Obstetrics and Gynecology The Methodist Health System Dallas Dallas, Texas New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2009 by The McGraw-Hill Companies, Inc.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • A Rare Case of Accidental Symphysiotomy (Syphysis Pubis Fracture) During Vaginal Delivery
    Case Report DOI: 10.18231/2394-2754.2017.0102 A rare case of accidental symphysiotomy (syphysis pubis fracture) during vaginal delivery Nishant H. Patel1,*, Bhavesh B. Aiarao2, Bipin Shah3 1Resident, 2Associate Professor, 3Professor & HOD, Dept. of Obstetrics & Gynecology, CU Shah Medical College & Hospital, Surendranagar, Gujarat *Corresponding Author: Email: [email protected] Abstract A 25 year old female was referred to C. U. Shah Medical College and Hospital on her 1st post-partum day for post partum hemorrhage and associated widening of pubic symphysis 1 hour after delivering a healthy male child weighing 2.7 with complaints of bleeding per vaginum. Uterus was well contracted & widening of pubic symphysis was noted on local examination. Exploration followed by paraurethral and vaginal wall tear repair was done under short GA. X-Ray pelvis revealed fracture of pubic symphysis and hence post procedure patient was given complete bed rest along with pelvic binder under adequate antibiotic coverage. Patient took discharge against medical advice on post-partum day 10. Patient was discharged on hematinics and advised to take complete bed rest and use pelvic binder for 30 days. Received: 26th March, 2017 Accepted: 19th September, 2017 Introduction On investigation her hemoglobin was found to be The pubic symphysis is a midline, non-synovial 7.01 g/dl, WBC count of 13,200 per mm3 and platelet joint that connects the right and left superior pubic rami. count was 2,72,000 per mm3. The interposed fibrocartilaginous disk is reinforced by a Patient was shifted to OT for exploration with series of ligaments that attach to it.
    [Show full text]
  • LSS Modules 1&2: Introduction & Antenatal
    Life-Saving Skills Manual for Midwives 4th Edition “Used since 1990 by doctors, nurses, midwives, and other skilled birth attendants...” Module 1. Introduction Module 2. Antenatal About the Life Saving Skills Manual Fourth Edition Materials The Life-Saving Skills Manual for Midwives,* and its • Index for the entire manual is found inside the back cover training program process, builds on years of experience of of each book. The index lists the subjects in alphabetical midwives practicing in rural and urban areas. The critical order. Some subjects may be listed under more than one issues of family and community support and education are name. For example, information on hemorrhage, may be woven throughout the manual. The LSS Manual is found under hemorrhage or bleeding. focused on strengthening the capacity of midwives and • Page numbers are numbered with both the module others with midwifery skills to save the lives of women and number and the page number. For example, the babies. The management, medications, equipment and number 5.3 is found in Module 5 on page 3. To find procedures suggested in the manual assume that only the rd laceration of the cervix – look in the index, it is listed with most basic provisions are usually available (LSS 3 Edition, number 4 indicating Module 4. Module 4 table of contents 1998). Cervical Laceration is listed on page 4.23. The information is on page 23. What is the LSS Manual? • Continuing education of critical knowledge for What is the Guide for Caregivers? practicing midwives, nurses, doctors, other skilled birth attendants It is a separate and smaller book that comes with the LSS Manual for use when learning and giving care.
    [Show full text]